Bristol-Myers to Post 4th-Quarter Charges: Bristol-Myers Squibb...

Bristol-Myers to Post 4th-Quarter Charges: Bristol-Myers Squibb Co. said it is taking two fourth-quarter charges totaling about $690 million after tax as it continues the process of blending two big pharmaceutical companies. The larger charge, an estimated $740 million before tax, will be taken as part of a plan to integrate newly merged businesses and reorganize on a worldwide basis. The two charges will reduce after-tax income by about $690 million. Financial results for the fourth quarter, which ended Dec. 31, are due to be issued later this month.